Behavioral models of Parkinson's disease in rodents: A new look at an old problem

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Movement Disorders

• Publication date

  2006-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/mds.21010PMID 16830310
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: have we wasted our time?

  2006cited by this paper
• Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?

  2006cited by this paper
• Parkin-deficient mice are not a robust model of parkinsonism.

  2005cited by this paper
• Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.

  2005cited by this paper
• 3,4-Dihydroxyphenylalanine Reverses the Motor Deficits in Pitx3-Deficient Aphakia Mice: Behavioral Characterization of a Novel Genetic Model of Parkinson's Disease

  2005cited by this paper
• Overexpression of Superoxide Dismutase or Glutathione Peroxidase Protects against the Paraquat + Maneb-induced Parkinson Disease Phenotype*

  2005cited by this paper
• Testing forelimb placing "across the midline" reveals distinct, lesion-dependent patterns of recovery in rats.

  2005cited by this paper
• Age-dependent dopaminergic dysfunction in Nurr1 knockout mice.

  2005cited by this paper
• Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1.

  2005cited by this paper
• Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity.

  2005cited by this paper
• The Pedunculopontine and Reinforcement

  2005cited by this paper
• Propriospinal Circuitry Underlying Interlimb Coordination in Mammalian Quadrupedal Locomotion

  2005cited by this paper
• Effects of riluzole on combined MPTP + 3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice

  2005cited by this paper
• Dynamic estimation of hand position is abnormal in Parkinson's disease.

  2004cited by this paper
• THE BEHAVIOR OF THE LABORATORY RAT A Handbook with Tests

  2004cited by this paper
• Cortical and brainstem control of locomotion.

  2004cited by this paper
• Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.

  2004cited by this paper
• A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function.

  2004cited by this paper
• Direct and indirect pathways for corticospinal control of upper limb motoneurons in the primate.

  2004cited by this paper
• The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA.

  2004cited by this paper
• Variability in fundamental frequency during speech in prodromal and incipient Parkinson's disease: a longitudinal case study.

  2004cited by this paper
• Attenuation of paraquat-induced motor behavior and neurochemical disturbances by L-valine in vivo.

  2004cited by this paper
• Rotenone induces non‐specific central nervous system and systemic toxicity

  2004cited by this paper
• Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone.

  2004cited by this paper
• Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein

  2004cited by this paper
• The effects of chronic L-DOPA therapy on pharmacodynamic parameters in a rat model of motor response fluctuations.

  2003cited by this paper
• Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons

  2003cited by this paper
• Age‐related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype

  2003cited by this paper
• Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats

  2003cited by this paper
• Brain-dependent movements and cerebral-spinal connections: key targets of cellular and behavioral enrichment in CNS injury models.

  2003cited by this paper
• Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons*

  2003cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003cited by this paper
• Transverse rotation and longitudinal translation during prosthetic gait--a literature review.

  2003cited by this paper
• Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation.

  2003cited by this paper
• Embryonic mesencephalic grafts increase levodopa‐induced forelimb hyperkinesia in parkinsonian rats

  2003cited by this paper
• Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice.

  2003cited by this paper
• Interactions of paraquat and triadimefon: behavioral and neurochemical effects.

  2003cited by this paper
• High frequency stimulation of the subthalamic nucleus improves treadmill locomotion in unilateral 6-hydroxydopamine lesioned rats.

  2003cited by this paper
• Pitx3 is required for development of substantia nigra dopaminergic neurons

  2003cited by this paper
• Distinct forelimb and hind limb stepping impairments in unilateral dopamine-depleted rats: use of the rotorod as a method for the qualitative analysis of skilled walking.

  2003cited by this paper
• Should the injured and intact hemispheres be treated differently during the early phases of physical restorative therapy in experimental stroke or parkinsonism?

  2003cited by this paper
• Somatodendritic dopamine release in rat substantia nigra influences motor performance on the accelerating rod.

  2003cited by this paper
• Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism.

  2003cited by this paper
• Behavioral sensitization to amphetamine in rats: changes in the rhythm of head movements during focused stereotypies

  2003cited by this paper
• Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice.

  2003cited by this paper
• Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of l-dopa using rAAV-mediated gene transfer

  2002cited by this paper
• Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease

  2002cited by this paper
• Forced Nonuse in Unilateral Parkinsonian Rats Exacerbates Injury

  2002cited by this paper
• Anatomical correlates of locomotor recovery following dorsal and ventral lesions of the rat spinal cord.

  2002cited by this paper
• Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  2002cited by this paper
• Forced limb-use and recovery following brain injury.

  2002cited by this paper
• Red nucleus projections to distinct motor neuron pools in the rat spinal cord

  2002cited by this paper
• Book Review: Forced Limb-Use and Recovery following Brain Injury

  2002cited by this paper
• L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function.

  2002cited by this paper
• Animal models of neurological deficits: how relevant is the rat?

  2002cited by this paper
• Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance.

  2002cited by this paper
• The fallacy of behavioral phenotyping without standardisation

  2002cited by this paper
• Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment.

  2001cited by this paper
• Fate of Midbrain Dopaminergic Neurons Controlled by the Engrailed Genes

  2001cited by this paper
• A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor.

  2001cited by this paper
• Experimental models of Parkinson's disease

  2001cited by this paper
• Forced Limb-Use Effects on the Behavioral and Neurochemical Effects of 6-Hydroxydopamine

  2001cited by this paper
• The parkinsonian toxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP): a technical review of its utility and safety

  2001cited by this paper
• Contributions of the reticulospinal system to the postural adjustments occurring during voluntary gait modifications.

  2001cited by this paper
• Fluctuations in response to treatment for Parkinson's disease.

  2001cited by this paper
• Chronic levodopa therapy does not improve skilled reach accuracy or reach range on a pasta matrix reaching task in 6‐OHDA dopamine‐depleted (hemi‐Parkinson analogue) rats

  2001cited by this paper
• Behavioral phenotyping of the MPTP mouse model of Parkinson's disease.

  2001cited by this paper
• Pathophysiology of bradykinesia in Parkinson's disease.

  2001cited by this paper
• CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury.

  2000cited by this paper
• Synaptic organisation of the basal ganglia

  2000cited by this paper
• MPTP Susceptibility in the Mouse: Behavioral, Neurochemical, and Histological Analysis of Gender and Strain Differences

  2000cited by this paper
• Effect of acute L-Dopa pretreatment on apomorphine-induced rotational behavior in a rat model of Parkinson's disease.

  2000cited by this paper
• Parkinson’s disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system

  2000cited by this paper
• Chronic systemic pesticide exposure reproduces features of Parkinson's disease

  2000cited by this paper
• Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6‐OHDA lesion model depends on the site of administration of the trophic factor

  2000cited by this paper
• Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

  2000cited by this paper
• Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions.

  1999cited by this paper
• The freezing of time as a presenting symptom of Parkinson's disease.

  1999cited by this paper
• Complete locomotor recovery following corticospinal tract lesions: measurement of ground reaction forces during overground locomotion in rats.

  1999cited by this paper
• The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

  1999cited by this paper
• The reach-to-grasp movement in Parkinson’s disease: response to a simultaneous perturbation of object position and object size

  1999cited by this paper
• Dietary restriction and 2‐deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease

  1999cited by this paper
• Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus.

  1999cited by this paper
• The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism.

  1998cited by this paper
• Paw and limb use in skilled and spontaneous reaching after pyramidal tract, red nucleus and combined lesions in the rat: behavioral and anatomical dissociations.

  1998cited by this paper
• Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

  1998cited by this paper
• Coding of Serial Order by Neostriatal Neurons: A “Natural Action” Approach to Movement Sequence

  1998cited by this paper
• Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test.

  1997cited by this paper
• Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion.

  1997cited by this paper
• An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism.

  1997cited by this paper
• Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic.

  1995cited by this paper
• Nigral and extranigral pathology in Parkinson's disease.

  1995cited by this paper
• Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test

  1995cited by this paper
• In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.

  1994cited by this paper
• Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration.

  1994cited by this paper
• Input-output organization of the sensorimotor striatum in the squirrel monkey

  1994cited by this paper
• A radical hypothesis for neurodegeneration.

  1993cited by this paper
• Inhibitory effects of calcium channel antagonists on motor dysfunction induced by intracerebroventricular administration of paraquat.

  1993cited by this paper
• A new motor test sensitive to aging and dopaminergic function.

  1991cited by this paper
• Areal distributions of cortical neurons projecting to different levels of the caudal brain stem and spinal cord in rats.

  1990cited by this paper

• Coactivation of CB1 and GPR55 promotes GABA release and motor behavior at striatonigral terminals through increased dimerization induced by CB1 activation

  2026cites this paper
• Chenodeoxycholic Acid-Mediated neuroprotection via α-synuclein and BDNF Modulation in MPTP-Induced mouse model of Parkinson's disease.

  2025cites this paper
• Research advances in dysphagia animal models

  2025cites this paper
• New insights on the regulators and inhibitors of RhoA-ROCK signalling in Parkinson’s disease

  2025cites this paper
• USP18 is a key regulator of immune function in mouse midbrain microglia.

  2025cites this paper
• The Leucine-Rich Repeat Kinase 2 Variant LRRK2G2019S Up-Regulates L-Type (CaV1.3) Calcium Channel via the CaVβ3 Subunit: Possible Role in the Pathogenesis of Parkinson’s Disease

  2025cites this paper
• Modeling neurodegeneration and neuroinflammation in Parkinson's Disease: Animal-based strategies.

  2025cites this paper
• Brain Organoid Transplantation: A Comprehensive Guide to the Latest Advances and Practical Applications—A Systematic Review

  2025cites this paper
• An L-shaped flexible neural implant for chronic ECoG signal acquisition in M2 region of control and Parkinsonian rat models

  2025cites this paper
• Dietary supplementation with 6% blueberries (Vaccinium corymbosum L.) attenuates neurodegeneration and motor deficits in a Parkinson's Disease model.

  2025cites this paper
• ND‐AMD: A Web‐Based Database for Animal Models of Neurological Disease With Analysis Tools

  2025cites this paper
• A Scoping Review of Neurotoxic and Behavioral Outcomes Following Polychlorinated Biphenyl (PCB) Exposure in Post-Weaned Rodents

  2025cites this paper
• Bridging the gap in Parkinson’s disease research: from general pathophysiology to advanced 3d cell culture models

  2025cites this paper
• Unrevealing the molecular mechanisms of MPTP-induced Parkinson’s in experimental animals

  2025cites this paper
• Effect of methylglyoxal on Parkinson’s disease pathophysiology in the rotenone model

  2024cites this paper
• Aqueous extract of Swietenia macrophylla leaf exerts an anti-inflammatory effect in a murine model of Parkinson’s disease induced by 6-OHDA

  2024cites this paper
• Positive relation between dopamine neuron degeneration and metabolic connectivity disruption in the MPTP plus probenecid mouse model of Parkinson's disease.

  2024cites this paper
• Neurobehavioral Testing as Cognitive Function Evaluation tool in Experimentally Induced Neurodegeneration in Mice

  2024cites this paper
• Experimental Parkinson Models and Green Chemistry Approach.

  2024cites this paper
• CalDAG-GEFI acts as a guanine nucleotide exchange factor for LRRK2 to regulate LRRK2 function and neurodegeneration

  2024cites this paper
• TAT-PPA1 protects against oxidative stress-induced loss of dopaminergic neurons.

  2024cites this paper
• Experimental models of Parkinson's disease: Challenges and Opportunities.

  2024cites this paper
• Diosgenin derivative ML5 attenuates MPTP-induced neuronal impairment via regulating AMPK/PGC-1α-mediated mitochondrial biogenesis and fusion/fission.

  2024cites this paper
• Early α-synuclein/synapsin III co-accumulation, nigrostriatal dopaminergic synaptopathy and denervation in the MPTPp mouse model of Parkinson's Disease.

  2024cites this paper
• Construct, Face, and Predictive Validity of Parkinson’s Disease Rodent Models

  2024cites this paper
• Benfotiamine protects MPTP-induced Parkinson’s disease mouse model via activating Nrf2 signaling pathway

  2024cites this paper
• Animal models in neuroscience with alternative approaches: Evolutionary, biomedical, and ethical perspectives

  2024cites this paper
• Non-transgenic models of Parkinson's disease: the pursuit of a resemblance

  2024cites this paper
• Medium-Term Effect of Pedunculopontine Nucleus Neurotoxic Lesion on Motor Function and Gene Expression of Protein Related to Dopaminergic Homeostasis in Rat

  2023cites this paper
• Intranasal cerium oxide nanoparticles improves locomotor activity and reduces oxidative stress and neuroinflammation in haloperidol-induced parkinsonism in rats

  2023cites this paper
• New Pieces for an Old Puzzle: Approaching Parkinson’s Disease from Translatable Animal Models, Gut Microbiota Modulation, and Lipidomics

  2023cites this paper
• Parkinson’s Disease: Exploring Different Animal Model Systems

  2023cites this paper
• Impaired aldehyde detoxification exacerbates motor deficits in an alpha‐synuclein mouse model of Parkinson's disease

  2023cites this paper
• Bioactive strawberry fruit (Arbutus unedo L.) extract remedies paraquat-induced neurotoxicity in the offspring prenatally exposed rats

  2023cites this paper
• Mice Expressing A53T/A30P Mutant Alpha-Synuclein in Dopamine Neurons Do Not Display Behavioral Deficits

  2023cites this paper
• Effects of cannabinoids in Parkinson’s disease animal models: a systematic review and meta-analysis

  2022cites this paper
• A Newly Identified Monoterpenoid-Based Small Molecule Able to Support the Survival of Primary Cultured Dopamine Neurons and Alleviate MPTP-Induced Toxicity In Vivo

  2022cites this paper
• Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects

  2022cites this paper
• Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects

  2022cites this paper
• Biosensors toward behavior detection in diagnosis of alzheimer’s disease

  2022cites this paper
• Neuroprotective effect of thiamine-producing lactic acid bacteria in a murine Parkinsonian model.

  2022cites this paper
• Transcriptional Profiling Reveals Brain Region-Specific Gene Networks Regulated in Exercise in a Mouse Model of Parkinson’s Disease

  2022cites this paper
• Striatal mechanisms of turning behaviour following unilateral dopamine depletion in mice

  2022cites this paper
• A hacked kitchen scale-based system for quantification of grip strength in rodents

  2022influential citation
• Temporal Phenotypic Changes in Huntington’s Disease Models for Preclinical Studies

  2022cites this paper
• A translational perspective on pathophysiological changes of oscillatory activity in dystonia and parkinsonism.

  2022cites this paper
• Parasitoid wasp venom manipulates host innate behavior via subtype-specific dopamine receptor activation

  2022cites this paper
• Assays of Tongue Force, Timing, and Dynamics in Rat and Mouse Models.

  2022cites this paper
• Presynaptic nigral GPR55 receptors stimulate [3H]‐GABA release through [3H]‐cAMP production and PKA activation and promote motor behavior

  2022cites this paper
• LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease

  2022cites this paper
• Resilin, an insect-derived elastomeric protein, protects dopaminergic neurons in Parkinson disease models.

  2022cites this paper
• The pyrethroids metabolite 3-phenoxybenzoic acid induces dopaminergic degeneration.

  2022cites this paper
• TRPV4 contributes to ER stress and inflammation: implications for Parkinson’s disease

  2022cites this paper
• MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons.

  2021cites this paper
• Identification of effective features of LFP signal for making closed-loop deep brain stimulation in parkinsonian rats

  2021cites this paper
• Abnormal Cortico-Basal Ganglia Neurotransmission in a Mouse Model of l-DOPA-Induced Dyskinesia

  2021cites this paper
• Protective mechanism of Syringic acid in an experimental model of Parkinson’s disease

  2021cites this paper
• Unraveling the Neuroprotective Effect of Tinospora cordifolia in a Parkinsonian Mouse Model through the Proteomics Approach.

  2021cites this paper
• Tocotrienols Ameliorate Neurodegeneration and Motor Deficits in the 6-OHDA-Induced Rat Model of Parkinsonism: Behavioural and Immunohistochemistry Analysis

  2021cites this paper
• griPASTA: A hacked kitchen scale-based system for quantification of grip strength in rodents

  2020cites this paper
• Which Zebrafish Strains Are More Suitable to Perform Behavioral Studies? A Comprehensive Comparison by Phenomic Approach

  2020cites this paper
• Progress in LRRK2-Associated Parkinson’s Disease Animal Models

  2020cites this paper
• Alpha-Lipoic Acid Mediates Clearance of Iron Accumulation by Regulating Iron Metabolism in a Parkinson’s Disease Model Induced by 6-OHDA

  2020cites this paper
• A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2

  2020cites this paper
• Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson’s Disease

  2020cites this paper
• The pesticide fipronil injected into the substantia nigra of male rats decreases striatal dopamine content: a neurochemical, immunohistochemical and behavioral study.

  2020cites this paper
• Parvalbumin+ and Npas1+ Pallidal Neurons Have Distinct Circuit Topology and Function

  2020cites this paper
• Neuroprotective and anti-inflammatory effects of a therapy combining agonists of nicotinic α7 and σ1 receptors in a rat model of Parkinson’s disease

  2020cites this paper
• Long-Term Treatment with Fluvoxamine Decreases Nonmotor Symptoms and Dopamine Depletion in a Postnatal Stress Rat Model of Parkinson's Disease

  2020cites this paper
• Motor Coordination Disorders Evaluated through the Grid Test and Changes in the Nigral Nrf2 mRNA Expression in Rats with Pedunculopontine Lesion

  2020cites this paper
• Subthalamic beta oscillations correlate with dopaminergic degeneration in experimental parkinsonism.

  2020cites this paper
• Basal ganglia circuits

  2020cites this paper
• Translocator protein 18 ligand Emapunil protects against neurodegeneration in the MPTP mouse model of Parkinsonism

  2020cites this paper
• Historical Perspective: Models of Parkinson’s Disease

  2020cites this paper
• K369I tau mice demonstrate a shift towards striatal neuron burst firing and goal-directed behaviour.

  2020cites this paper
• Deep brain stimulation in Parkinson’s disease patients and routine 6‐OHDA rodent models: Synergies and pitfalls

  2020cites this paper
• 6-hydroxydopamine-induced model of Parkinson's disease

  2020cites this paper
• Photobiomodulation Mitigates Cerebrovascular Leakage Induced by the Parkinsonian Neurotoxin MPTP

  2019cites this paper
• Classic animal models of Parkinson's disease: a historical perspective.

  2019cites this paper
• Efecto de la deficiencia transitoria de glutatión sobre el funcionamiento de la vía nigro-estriatal y la conducta motora de ratas

  2019cites this paper
• PINK1 deficiency is associated with increased deficits of adult hippocampal neurogenesis and lowers the threshold for stress‐induced depression in mice

  2019cites this paper
• The effects of zonisamide on L‐DOPA‐induced dyskinesia in Parkinson's disease model mice

  2019cites this paper
• Effects of Substantia Nigra pars compacta lesion on the behavioral sequencing in the 6‐OHDA model of Parkinson’s disease

  2019cites this paper
• Regulatory non-coding RNAs in nervous system development and disease.

  2019cites this paper
• Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP‐induced model of Parkinson's disease

  2019cites this paper
• Botulinum Neurotoxin-A Injected Intrastriatally into Hemiparkinsonian Rats Improves the Initiation Time for Left and Right Forelimbs in Both Forehand and Backhand Directions

  2019cites this paper
• Naturally occurring autoantibodies against α-synuclein rescues memory and motor deficits and attenuates α-synuclein pathology in mouse model of Parkinson's disease.

  2019cites this paper
• Myelinating Schwann cells ensheath multiple axons in the absence of E3 ligase component Fbxw7

  2019cites this paper
• Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson’s disease

  2019cites this paper
• Parkinson's disease: Mechanisms, translational models and management strategies

  2019cites this paper
• 7,8-Dihydroxyflavone Protects Nigrostriatal Dopaminergic Neurons from Rotenone-Induced Neurotoxicity in Rodents

  2019cites this paper
• Role of adenosine A2A receptors in motor control: relevance to Parkinson’s disease and dyskinesia

  2018cites this paper
• NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson’s Disease

  2018cites this paper
• Comprehensive Characterization of the Pyroglutamate Amyloid-β Induced Motor Neurodegenerative Phenotype of TBA2.1 Mice

  2018cites this paper
• Does Repeated Methamphetamine Exposure at Different Regimens Cause Parkinsonian-Like Behavior in Rats?

  2018cites this paper
• Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets

  2018cites this paper
• The Effect of Sodium Metabisulphite on Locomotor Activity in the Experimental Model of Parkinson’s Disease: The Role of Cyclooxygenase

  2018cites this paper
• Insights into the Cyclooxygenase Pathway in a Progressive Rat Model of Parkinson’s Disease Induced by Prostaglandin J2: Protection with Ibuprofen

  2018cites this paper
• Behavioral and neurochemical responses derived from dopaminergic intrastriatal grafts in hemiparkinsonian rats engaged in a novel motor task.

  2018cites this paper
• The Role of Human α7-Nicotinic Acetylcholine Receptors in Mediating Neuroprotective Action of Curcumin

  2018cites this paper